Two Stocks To Tuck Away: Jagged Peak Energy Inc. (JAG), Novartis AG (NVS)

The shares of Jagged Peak Energy Inc. (NYSE:JAG) has been pegged with a rating of In-line by Imperial Capital in its latest research note that was published on July 17th, 2019. The research company has also assigned a $9 price target. Imperial Capital wasn’t the only research firm that published a report of Jagged Peak Energy Inc., with other equities research analysts also giving their opinion on the stock. Piper Jaffray advised investors in its research note published on July 8th, 2019, to Overweight the JAG stock while also putting a $11 price target. The stock had earned Buy rating from Williams Capital Group when it published its report on June 17th, 2019. That day the Williams Capital Group set price target on the stock to $13. The stock was given Buy rating by SunTrust in its report released on April 2nd, 2019, the day when the price target on the stock was placed at $15. Imperial Capital was of a view that JAG is Outperform in its latest report on March 4th, 2019 while giving it a price target of $16. Macquarie thinks that JAG is worth Neutral rating. This was contained in the firm’s report on December 20th, 2018.

Amongst the analysts that rated the stock, 0 have recommended investors to sell it, 13 believe it has the potential for further growth, thus rating it as Hold while 5 advised investors to purchase the stock. The consensus currently stands at a Hold while its average price target is $11.43. The price of the stock the last time has raised by 6.98% from its Week high price while it is raised higher than its 52-Week low price. A look at the stock’s other technical shows that its 14-day RSI now stands at 36.44.

The shares of the company dipped by -0.15% during the trading session on Tuesday, reaching a low of $6.30 while ending the day at $6.51. During the trading session, a total of 2.36 million shares were traded which represents a -57.59% decline from the average session volume which is 1.50M shares. JAG had ended its last session trading at 6.52. Jagged Peak Energy Inc. currently has a market cap of $1.36B, while its P/E ratio stands at 12.64, while its P/E earnings growth sits at 2.34. Jagged Peak Energy Inc. debt-to-equity ratio currently stands at 0.64, while its quick ratio hovers at 0.40. JAG 52-week low price stands at $6.09 while its 52-week high price is $14.74.

The company in its last quarterly report recorded $0.09 earnings per share which is below the $0.13 predicted by most analysts. The Jagged Peak Energy Inc. generated $129.60 million in revenue during the last quarter, which is slightly lower than the $133.88 million predicted by analysts. In the second quarter last year, the firm recorded $0.13 earnings per share. Compared to the same quarter last year, the firm’s revenue was down by -44.44%. Jagged Peak Energy Inc. has the potential to record 0.52 EPS for the current fiscal year, according to equities analysts.

Investment analysts at Liberum published a research note on April 25th, 2019 where it informed investors and clients that Novartis AG (NYSE:NVS) is now rated as Buy. Piper Jaffray also rated NVS as Initiated on July 8th, 2019, with its price target of $70 suggesting that NVS could surge by 9.78% from its current share price. Even though the stock has been trading at $91.10/share, analysts expect it to surge higher by 0.02% to reach $101.00/share. It started the day trading at $91.38 and traded between $90.57 and $91.12 throughout the trading session.

A look at its technical shows that NVS’s 50-day SMA is 90.89 while its 200-day SMA stands at 82.12. The stock has a high of $95.00 for the year while the low is $72.63. The company’s P/E ratio currently sits at 31.36, while the P/B ratio is 4.09. At the moment, only of Novartis AG shares were sold short. The company’s average trading volume currently stands at 2.10M shares, which means that the short-interest ratio is just 1.53 days. Over the past seven days, the company moved, with its shift of 3.29%. Looking further, the stock has raised 12.87% over the past 90 days while it gained 14.50% over the last six months.

The change in the stock’s fortunes has led to several institutional investors altering their holdings of the stock. Dodge Cox sold more NVS shares, decreasing its portfolio by -1.23% during the last quarter. This move now sees Dodge Cox selling -454,023 shares in the last quarter, thus it now holds 36,344,595 shares of NVS, with a total valuation of $3,328,438,010. PRIMECAP Management Co meanwhile bought more NVS shares in the recently filed quarter, changing its stake to $2,184,843,841 worth of shares. Franklin Mutual Advisers LLC followed the path by increasing its NVS portfolio by +0.07% in the quarter. This means that Franklin Mutual Advisers LLC bought 10,161 shares in the last quarter and now controls 14,016,677 shares of the NVS stock, with the valuation hitting $1,283,647,280.

Similarly, Fidelity Management Research Co increased its Novartis AG shares by +26.14% during the recently filed quarter. After buying 1,664,503 shares in the last quarter, the firm now controls 8,031,804 shares of Novartis AG which are valued at $735,552,610. In the same vein, Loomis Sayles Co LP increased its Novartis AG shares by during the most recent reported quarter. The firm bought 47,186 shares during the quarter which increased its stakes to 7,011,335 shares and is now valued at $642,098,059. Following these latest developments, around 9.30% of Novartis AG stocks are owned by institutional investors and hedge funds.